Jitendra Kanodia is the Director of Clinical and Translational Pharmacology at Theravance Biopharma in South San Francisco, California, USA. He is also the Project Team Leader for a Phase-1 clinical asset in development for treatment of pulmonary diseases. Jitendra received his Ph.D. in Chemical and Biological Engineering from Princeton University, USA and his Bachelors in Technology degree from IIT Madras.
Jitendra has played a composite role of systems biologist, quantitative systems pharmacologist, non-clinical PKPD and clinical pharmacologist at Theravance, Genentech and Merrimack. He is passionate about utilizing quantitative methods to enable more efficient decision-making during drug development and especially interested in the early phases of clinical development (e.g. experimental medicine and Phase 1-2 studies)